Our clinical trial experience includes, but is not limited to, the following indications:

• Diabetes
• Obesity
• Dyslipidemia
• Metabolic Syndrome

ICON has conducted diabetes trials in all global regions and has particular experience in running studies in emerging regions such as Eastern Europe, India and South America where there are large pools of treatment naïve patients. ICON has a network of offices in these regions and has developed strong relationships with investigator sites to ensure high rates of patient enrolment and retention.

To overcome the unique challenges of clinical development in metabolic disorders, ICON has created a team of in-house global experts to support and oversee drug development programmes. The TAG members share a common expertise in metabolic disorders in their areas of competence; medical, laboratory, imaging operations, statistics and consulting. They provide therapeutic indication training to the project team to enable studies to get up and running soon and to meet aggressive project timelines. TAG members are a permanent resource for the study team throughout the course of the project.